Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Short term Debt (2018 - 2025)

Rockwell Medical (RMTI) has disclosed Short term Debt for 10 consecutive years, with $1.8 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Short term Debt fell 23.04% year-over-year to $1.8 million, compared with a TTM value of $1.8 million through Sep 2025, down 23.04%, and an annual FY2024 reading of $2.4 million, down 5.16% over the prior year.
  • Short term Debt was $1.8 million for Q3 2025 at Rockwell Medical, down from $2.4 million in the prior quarter.
  • Across five years, Short term Debt topped out at $21.1 million in Q2 2021 and bottomed at $171000.0 in Q1 2021.
  • Average Short term Debt over 5 years is $4.5 million, with a median of $2.5 million recorded in 2023.
  • The sharpest move saw Short term Debt skyrocketed 11046.1% in 2021, then crashed 75.72% in 2022.
  • Year by year, Short term Debt stood at $7.4 million in 2021, then crashed by 30.48% to $5.1 million in 2022, then plummeted by 51.28% to $2.5 million in 2023, then decreased by 5.16% to $2.4 million in 2024, then dropped by 26.19% to $1.8 million in 2025.
  • Business Quant data shows Short term Debt for RMTI at $1.8 million in Q3 2025, $2.4 million in Q1 2025, and $2.4 million in Q4 2024.